Papers By Louis Galambos

"The Fragile Innovation System in Drug Discovery," Speech given to the Institute of Medicine’s
Forum on Drug Discovery, Development, and Translation meeting June 30, 2005. http://www.iom.edu/Object.File/Master/29/562/0.pdf

“Intellectual Property and Pharmaceuticals: A brief excursion through history,” paper presented to the International Intellectual Property Institute conference on Intellectual Property and International Public Health, Monday, October 6, 2003 at Georgetown University. http://www.iipi.org/Conferences/IP&Health/galambos_paper.pdf

Co-author (with Jeffrey Sturchio), “Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation,” Business History Review, 72 (1998), 250-78.

“Theodore N. Vail and the Role of Innovation in the Modern Bell System,” a version of this article appeared in Annali di Storia Dell’Impresa 4 (Milan, 1989), 442-54; the final version is in the Business History Review, 66 (Spring 1992), 95-126.

“What Have CEOs Been Doing?” Journal of Economic History, XLVIII (June 1988), 243-58. This was my presidential address to the Economic History Association.

“The Emerging Organizational Synthesis in Modern American History,” The Business History Review, XLIV, No. 3 (Autumn 1970), 279-90. This article has been reprinted in Edwin J. Perkins, Men and Organizations: The American Economy in the Twentieth Century (N.Y.: Putnam, 1977). The most recent version of the organizational synthesis is available in Business History Review 79 (Spring 2005)

"Innovation and Industry Evolution: A Comment," in Mariana Mazzucato and Giovanni Dosi eds, Knowledge Accumulation and Industry Evolution: the Case of Pharma-Biotech, Cambridge University Press 2006, Page 145-160.